Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4
- PMID: 11099315
- DOI: 10.1093/intimm/12.12.1749
Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4
Abstract
SAP, the gene that is altered or absent in the X-linked lymphoproliferative syndrome (XLP), encodes a small protein that comprises a single SH2 domain and binds to the cell-surface protein SLAM which is present on activated or memory T and B cells. Because defective NK cell activity also has been reported in XLP patients, we studied the SAP gene in NK cells. SAP was induced upon viral infection of SCID mice and shown to be expressed in NK cells by in vitro culturing in the presence of IL-2. Moreover, SAP was expressed in the NK cell lines YT and RNK 16. Because SLAM, the cell-surface protein with which SAP interacts, and 2B4, a membrane protein having sequence homologies with SLAM, also were found to be expressed on the surfaces of activated NK and T cell populations, they may access SAP functions in these populations. Whereas we found that 2B4 also binds SAP, 2B4-SAP interactions occurred only upon tyrosine phosphorylation of 2B4. By contrast, SLAM-SAP interactions were independent of phosphorylation of Y281 and Y327 on SLAM. As CD48, the ligand for 2B4, is expressed on the surface of Epstein-Barr virus (EBV)-infected B cells, it is likely that SAP regulates signal transduction through this pair of cell-surface molecules. These data support the hypothesis that XLP is a result of both defective NK and T lymphocyte responses to EBV. The altered responses may be due to aberrant control of the signaling cascades which are initiated by the SLAM-SLAM and 2B4-CD48 interactions.
Similar articles
-
Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.J Immunol. 2000 Sep 15;165(6):2932-6. doi: 10.4049/jimmunol.165.6.2932. J Immunol. 2000. PMID: 10975798
-
Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.Mol Cell Biol. 2004 Jun;24(12):5144-56. doi: 10.1128/MCB.24.12.5144-5156.2004. Mol Cell Biol. 2004. PMID: 15169881 Free PMC article.
-
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.J Exp Med. 2000 Aug 7;192(3):337-46. doi: 10.1084/jem.192.3.337. J Exp Med. 2000. PMID: 10934222 Free PMC article.
-
2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.Hum Immunol. 2000 Jan;61(1):39-43. doi: 10.1016/s0198-8859(99)00170-6. Hum Immunol. 2000. PMID: 10658976 Review.
-
NK cell regulation by SLAM family receptors and SAP-related adapters.Immunol Rev. 2006 Dec;214:22-34. doi: 10.1111/j.1600-065X.2006.00453.x. Immunol Rev. 2006. PMID: 17100873 Review.
Cited by
-
Fine-tuning of CD8(+) T-cell effector functions by targeting the 2B4-CD48 interaction.Immunol Cell Biol. 2016 Jul;94(6):583-92. doi: 10.1038/icb.2016.17. Epub 2016 Feb 10. Immunol Cell Biol. 2016. PMID: 26860368
-
2B4 utilizes ITAM-containing receptor complexes to initiate intracellular signaling and cytolysis.Mol Immunol. 2011 May;48(9-10):1149-59. doi: 10.1016/j.molimm.2011.02.008. Epub 2011 Mar 25. Mol Immunol. 2011. PMID: 21439641 Free PMC article.
-
Development and characterization of domain-specific monoclonal antibodies produced against human SLAMF9.Monoclon Antib Immunodiagn Immunother. 2014 Aug;33(4):209-14. doi: 10.1089/mab.2014.0010. Monoclon Antib Immunodiagn Immunother. 2014. PMID: 25170999 Free PMC article.
-
Responses to Microbial Challenges by SLAMF Receptors.Front Immunol. 2016 Jan 20;7:4. doi: 10.3389/fimmu.2016.00004. eCollection 2016. Front Immunol. 2016. PMID: 26834746 Free PMC article. Review.
-
X-linked lymphoproliferative disease: genetic lesions and clinical consequences.Curr Allergy Asthma Rep. 2002 Sep;2(5):361-7. doi: 10.1007/s11882-002-0068-0. Curr Allergy Asthma Rep. 2002. PMID: 12165201 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous